TBVI continuously works to support the development of new TB vaccine candidates. Our dedicated Product Advancement Experts are ready to help progress new vaccine candidates for patients who urgently require them.
For a comprehensive overview of (pre)clinical TB vaccine candidates, please consult the website of the Working Group on New TB Vaccines. We invite vaccine developers to share updates to keep the vaccine pipeline updated. Get in touch at info@tbvi.eu.
In December 2024, the Treatment Action Group (TAG) published the 2024 TB Vaccine Pipeline Report:
